Efficient Priming of CD8+ Memory T Cells Specific for a Subdominant Epitope Following Sendai Virus Infection

Journal of Immunology

Volumn 158, Issue 9, 1997, Pages 4301-4309

  Cole, Geoffrey A ^a   Hogg, Twala L ^a   Coppola, Michael A ^a   Woodland, David L ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; H2 ANTIGEN; NP PROTEIN; NUCLEOCAPSID PROTEIN; NUCLEOPROTEIN; PEPTIDE; VIRUS ANTIGEN; VIRUS VACCINE;

ANIMAL; ARTICLE; C57BL MOUSE; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EPITOPE MAPPING; FEMALE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MOUSE; PARAMYXOVIRUS; RNA VIRUS INFECTION;

ANIMALS; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; EPITOPE MAPPING; FEMALE; H-2 ANTIGENS; IMMUNOLOGIC MEMORY; MICE; MICE, INBRED C57BL; NUCLEOCAPSID PROTEINS; NUCLEOPROTEINS; PEPTIDES; RESPIROVIRUS; RESPIROVIRUS INFECTIONS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL CORE PROTEINS; VIRAL VACCINES;

EID: 0031134998     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. Reddehase, M. J., S. Jonjic, F. Weiland, W. Mutter, and U. H. Koszinowski. 1988. Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors. J. Virol. 62:1061.
2. Ada, G. L., and P. D. Jones. 1986. The immune response to influenza infection. Curr. Top. Microbiol. Immunol. 128:1.
3. Doherty, P. C., W. Allan, M. Eichelberger, and S. R. Carding. 1992. Roles of alpha beta and gamma delta T cell subsets in viral immunity. Annu. Rev. Immunol. 10:123.
4. + T cells. J. Immunol. 149:1319.
5. Townsend, A. R., J. Rothbard, F. M. Gotch, G. Bahadur, D. Wraith, and A. J. McMichael. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959.
6. Braciale, T. J., and V. L. Braciale. 1991. Antigen presentation: structural themes and functional variations. Immunol. Today 12:124.
7. Ortmann, B., M. J. Androlewicz, and P. Cresswell. 1994. MHC class I/beta 2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 368:864.
8. Yewdell, J. W., and J. R. Bennink. 1992. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv. Immunol. 52:1.
9. Cox, J. H., J. W. Yewdell, L. C. Eisenlohr, P. R. Johnson, and J. R. Bennink. 1990. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science 247:715.
10. Townsend, A., C. Ohlen, J. Bastin, H. G. Ljunggren, L. Foster, and K. Karre. 1989. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340:443.
11. Kronenberg, M., G. Siu, L. E. Hood, and N. Shastri. 1986. The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition. Annu. Rev. Immunol. 4:529.
12. Garboczi, D. N., P. Ghosh, U. Utz, Q. R. Fan, W. E. Biddison, and D. C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134.
13. Garcia, K. C., M. Degano, R. L. Stanfield, A. Brunmark, M. R. Jackson, P. A. Peterson, L. Teyton, and I. A. Wilson. 1996. An alpha beta T cell receptor structure at 2.5A and its orientation in the TCR-MHC complex. Science 274:209.
14. Bergmann, C. C., L. Tong, R. Cua, J. Sensintaffar, and S. Stohlman. 1994. Differential effects of flanking residues on presentation of epitopes from chimeric peptides. J. Virol. 68:5306.
15. Eisenlohr, L. C. J. W. Yewdell, and J. R. Bennink. 1992. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 175:481.
16. Restifo, N. P., I. Bacik, K. R. Irvine, J. W. Yewdell, B. J. McCabe, R. W. Anderson, L. C. Eisenlohr, S. A. Rosenberg, and J. R. Bennink. 1995. Antigen processing in vivo and the elicitation of primary CTL responses. J. Immunol. 154:4414.
17. Shastri, N., T. Serwold, and F. Gonzalez. 1995. Presentation of endogenous peptide/MHC class I complexes is profoundly influenced by specific C-terminal flanking residues. J. Immunol. 155:4339.
18. al-Ramadi, B. K., M. T. Jelonek, L. F. Boyd, D. H. Margulies, and A. L. Bothwell. 1995. Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR. J. Immunol. 155:662.
19. Chen, W., S. Khilko, J. Fecondo, D. H. Margulies, and J. McCluskey. 1994. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J. Exp. Med. 180:1471.
20. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. Melief, C. Oseroff, L. Yuan, and J. Ruppert. 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153:5586.
21. Bergmann, C. C., L. Tong, R. V. Cua, J. L. Sensintaffar, and S. A. Stohlman. 1994. Cytotoxic T cell repertoire selection: a single amino acid determines alternative class I restriction. J. Immunol. 152:5603.
22. Bodmer, H. C. J. M. Bastin, B. A. Askonas, and A. R. Townsend. 1989. Influenza-specific cytotoxic T-cell recognition is inhibited by peptides unrelated in both sequence and MHC restriction. Immunology 66:163.
23. d restricted T cells. J. Immunol. 141:2289.
24. + CTL response to an influenza hemagglutinin epitope reflects limited T cell availability. J. Immunol. 157:505.
25. Daly, K., P. Nguyen, D. L. Woodland, and M. A. Blackman. 1995. Immunodominance of major histocompatibility complex class I-restricted influenza virus epitopes can be influenced by the T-cell receptor repertoire. J. Virol. 69:7416.
26. Gegin, C., and F. Lehmann-Grube. 1992. Control of acute infection with lymphocytic choriomeningitis virus in mice that cannot present an immunodominant viral cytotoxic T lymphocyte epitope. J. Immunol. 149:3331.
27. b mutant bm13 mice. J. Virol. 68:6038.
28. b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen. J. Virol. 69:6665.
29. b cells. J. Immunol. 152:4843.
30. b. J. Immunol. 129:689.
31. Nugent, C. T., J. M. McNally, R. Chervenak, R. M. Wolcott, and S. R. Jennings. 1995. Differences in the recognition of CTL epitopes during primary and secondary responses to herpes simplex virus infection in vivo. Cell Immunol. 165:55.
32. Nugent, C. T., R. M. Wolcott, R. Chervenak, and S. R. Jennings. 1994. Analysis of the cytolytic T-lymphocyte response to herpes simplex virus type 1 glycoprotein B during primary and secondary infection. J. Virol. 68:7644.
33. Chanock, R. M., and K. McIntosh. 1996. Parainfluenza Viruses. In Fields Virology. 3rd Ed. B. N. Fields, D. M. Knipe, and P. M. Howley, eds. Lippincott-Raven Press, Philadelphia, p. 1205.
34. Kast, W. M., L. Roux, J. Curren, H. J. Blom, A. C. Voordouw, R. H. Meloen, D. Kolakofsky, and C. J. Melief. 1991. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl. Acad. Sci. USA 88:2283.
35. Kast, W. M., A. M. Bronkhorst, L. P. de Waal, and C. J. Melief. 1986. Cooperation between cytotoxic and helper T lymphocytes in protection against lethal Sendai virus infection: protection by T cells is MHC- restricted and MHC-regulated: a model for MHC-disease associations. J. Exp. Med. 164:723.
36. Cole, G. A., T. L. Hogg, and D. L. Woodland. 1994. The MHC class I-restricted T cell response to Sendai virus infection in C57BL/6 mice: a single immunodominant epitope elicits an extremely diverse repertoire of T cells. Int. Immunol. 6:1767.
37. Schumacher, T. N., M. L. De Bruijn, L. N. Vernie, W. M. Kast, C. J. Melief, J. J. Neefjes, and H. L. Ploegh. 1991. Peptide selection by MHC class I molecules. Nature 350:703.
38. + cytotoxic T lymphocytes. Scand. J. Immunol. 42:66.
39. Kappler, J. W., B. Skidmore, J. White, and P. Marrack. 1981. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas: lack of independent antigen and H-2 recognition. J. Exp. Med. 153:1198.
40. Cole, G. A., V. K. Clements, E. P. Garcia, and S. Ostrand-Rosenberg. 1987. Allogeneic H-2 antigen expression is insufficient for tumor rejection. Proc. Natl. Acad. Sci. USA 84:8613.
41. Ostrand-Rosenberg, S., C. Roby, V. K. Clements, and G. A. Cole. 1991. Tumor-specific immunity can be enhanced by transfection of tumor cells with syngeneic MHC-class-II genes or allogeneic MHC-class-I genes. Int. J. Cancer 6(Suppl):61.
42. Karre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319:675.
43. Ljunggren, H. G., and K. Karre. 1985. Host resistance directed selectively against H-2-deficient lymphoma variants: analysis of the mechanism. J. Exp. Med. 162:1745.
44. + T-cell recognition is directed predominantly to the hemagglutinin-neuraminidase glycoprotein. J. Virol. 68:6863.
45. Smith, G. L., J. Z. Levin, P. Palese, and B. Moss. 1987. Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses. [Published erratum appears in 1988 Virology 163:259.] Virology 160:336.
46. + T cells. J. Immunol. 144:3980.
47. Jameson, S. C., and M. J. Sevan. 1992. Dissection of major histocompatibility complex (MHC) and T cell receptor contact residues in a Kb-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs. Eur. J. Immunol. 22:2663.
48. Loken, M. R., and A. M. Stall. 1982. Flow cytometry as an analytical and preparative tool in immunology. J. Immunol. Methods 50:R85.
49. d antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. J. Immunol. 125:2473.
50. Wysocki, L. J., and V. L. Sato. 1978. "Panning" for lymphocytes: a method for cell selection. Proc. Natl. Acad. Sci. USA 75:2844.
51. White, J., M. Blackman, J. Bill, J. Kappler, P. Marrack, D. P. Gold, and W. Born. 1989. Two better cell lines for making hybridomas expressing specific T ceil receptors. J. Immunol. 143:1822.
52. Woodland, D. L., H. P. Smith, S. Surman, P. Le, R. Wen, and M. A. Blackman. 1993. Major histocompatibility complex-specific recognition of Mls-1 is mediated by multiple elements of the T cell receptor. J. Exp. Med. 177:433.
53. Woodland, D., M. P. Happ, J. Bill, and E. Palmer. 1990. Requirement for cotolerogenic gene products in the clonal deletion of I-E reactive T cells. Science 247:964.
54. + T cells in lymph node and lung of mice with Sendai virus pneumonia by LECAM-1 and CD45RB phenotype. J. Immunol. 150:5494.
55. Taswell, C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126:1614.
56. Rammensee, H. G., T. Friede, and S. Stevanoviic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
57. b is sequence dependent. Eur. J. Immunol. 22:1603.
58. Schumacher, T. N., M. T. Heemels, J. J. Neefjes, W. M. Kast, C. J. Melief, and H. L. Ploegh. 1990. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell 62:563.
59. Casanova, J. L., and J. L. Muryanski. 1993. Antigen-selected T-cell receptor diversity and self-nonself homology. Immunol. Today 14:391.
60. de Waal, L. P., W. M. Kast, R. W. Melvold, and C. J. Melief. 1983. Regulation of the cytotoxic T lymphocyte response against Sendai virus analyzed with H-2 mutants. J. Immunol. 130:1090.
61. + cytolytic T cell responses. J. Exp. Med. 182:1663.
62. Schirmbeck, R., W. Bohm, K. Melber, and J. Reimann. 1995. Processing of exogenous heat-aggregated (denatured) and particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation. J. Immunol. 155:4676.
63. Koszinowski, U. H., M. J. Gethring, and M. Waterfield. 1977. T-cell cytotoxicity in the absence of viral protein synthesis in target cells. Nature 267:160.
64. Liu, T., X. Zhou, C. Orvell, E. Lederer, H. G. Ljunggren, and M. Jondal. 1995. Heat-inactivated Sendai virus can enter multiple MHC class I processing pathways and generate cytotoxic T lymphocyte responses in vivo. J. Immunol. 154:3147.
65. Zhou, X., R. Glas, F. Momburg, G. J. Hammerling, M. Jondal, and H. G. Ljunggren. 1993. TAP2-defective RMA-S cells present Sendai virus antigen to cytotoxic T lymphocytes. Eur. J. Immunol. 23:1796.
66. Wettstein, P. J., and D. W. Bailey. 1982. Immunodominance in the immune response to "multiple" histocompatibility antigens. Immunogenetics 16:47.
67. Doherty, P. C., W. E. Biddison, J. R. Bennink, and B. B. Knowles. 1978. Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype. J. Exp. Med. 148:534.
68. Zinkernagel, R. M., A. Althage, S. Cooper, G. Kreeb, P. A. Klein, B. Sefton, L. Flaherty, J. Stimpfling, D. Shreffler, and J. Klein. 1978. Ir genes in H-2 regulate generation of anti-viral cytotoxic T cells: mapping to K or D and dominance of unresponsiveness. J. Exp. Med. 148:592.
69. Doherty, P. C., and R. M. Zinkernagel. 1976. Specific immune lysis of paramyxo-virus-infected cells by H-2-compatible thymus-derived lymphocytes. Immunology 31:27.
70. Woodland, D. L., G. A. Cole, and P. C. Doherty. 1996. Viral immunity and vaccine strategies. In Concepts in Vaccine Development. S. H. E. Kaufman, ed. Walter de Gruyter, Berlin, p. 141.
71. + T cells in respiratory virus infections. J. Immunol. 154:6013.
72. + T-cell memory to viruses. Curr. Opin. Immunol. 6:545.
73. + T-cell memory determined by clonal burst size. Nature 369:652.
74. Pala, P., and B. A. Askonas. 1985. Induction of Kb-restricted anti-influenza cytotoxic T cells in C57BL mice: importance of stimulator cell type and immunization route. Immunology 55:601.
75. van der Most, R. G., A. Sette, C. Oseroff, J. Alexander, K. Murali-Krishna, L. L. Lau, S. Southwood, J. Sidney, R. W. Chesnut, M. Matloubian, and R. Ahmed. 1996. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 157:5543.
76. Bertoletti, A., A. Costanzo, F. V. Chisari, M. Levrero, M. Artini, A. Sette, A. Penna, T. Giuberti, F. Fiaccadori, and C. Ferrari. 1994. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J. Exp. Med. 180:933.
77. Bertoletti, A., A. Sette, F. V. Chisari, A. Penna, M. Levrero, M. De Carli, F. Fiaccadori, and C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407.
78. de Campos-Lima, P. O., V. Levitsky, J. Brooks, S. P. Lee, L. F. Hu, A. B. Rickinson, and M. G. Masucci. 1994. T cell responses and virus evolution: loss of HLA AI1-restricted CTL epitopes in Epstein-Barr virus isolates from highly AI1-positive populations by selective mutation of anchor residues. J. Exp. Med. 179:1297.
79. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, and A. Edwards. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369:403.
80. Pircher, H., D. Moskophidis, U. Rohrer, K. Burki, H. Hengartner, and R. M. Zinkernagel. 1990. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346:629.
81. Oukka, M., J. C. Manuguerre, N. Livaditis, S. Tourdot, N. Riche, I. Vergnon, P. Cordopatis, and K. Kosmatopoulos. 1996. Protection against lethal virus infection by vaccination with nonimmunodominant peptides. J. Immunol. 157:3039.